The FDA has approved CEFOTAN® (cefotetan) for Injection, USP from Teligent Inc.
The US Food and Drug Administration has approved Teligent, Inc.’s CEFOTAN® (cefotetan) for Injection, USP. Cefotetan injection is used to treat infections of the blood, bones, female reproductive organs, joints, lungs, skin, and urinary tract. It can also be used prior to surgery, to prevent infections. Cefotetan injection is in a class of medications called cephalosporin antibiotics, and works by killing bacteria.
Cefotetan for Injection, USP is available in 2 vial strengths. Each 1-gram vial contains cefotetan disodium, equivalent to 1-gram cefotetan activity and each 2-gram vial contains cefotetan disodium equivalent to 2-grams cefotetan activity. It is distributed in a Pharmacy Bulk Package containing 80 mg (3.5 mEq) of sodium per gram of cefotetan activity. Cefotetan for Injection, USP is a white to pale yellow powder; it is very soluble in water.
Some side effects of cefotetan for Injection, USP may be diarrhea, difficulty breathing/swallowing, dizziness, exhaustion, fast heartbeat, fever, hives, itching, redness, pain, or swelling at injection site, shortness of breath, and more.
For more information visit, https://www.nlm.nih.gov/medlineplus/druginfo/meds/a686015.html.—Alessia D’Anna
